http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
[PG-0009] Antioxidant activities and phytochemical contents of diverse representative tea germplasm
Gi-An Lee(Gi-An Lee),Nayoung Ro(Nayoung Ro),Do Yoon Hyun(Do Yoon Hyun),Gwang-Yeon Gi(Gwang-Yeon Gi),Kyung Jun Lee(Kyung Jun Lee),Weilan Li(Weilan Li),Eun Ae Yoo(Eun Ae Yoo),SooKyeong Lee(SooKyeong Lee 한국육종학회 2022 한국육종학회 공동학술발표집 Vol.2022 No.-
Evolution of Cavitation Bubble in Tap Water by Continuous-Wave Laser Focused on a Metallic Surface
Kim, Nayoung,Park, Hyungmin,Do, Hyungrok American Chemical Society 2019 Langmuir Vol.35 No.9
<P>As an example of photon-matter interaction, we experimentally investigate the temporal evolution of a millimeter-sized cavitation bubble, induced by focusing a continuous-wave laser on a metallic plate in tap water. Our major interests are to understand the mechanism of bubble growth/shrinkage for a long time duration up to <I>O</I>(10<SUP>2</SUP>) seconds and to draw the time-dependency relation of a bubble size, depending on the incident laser power. With the time passed after the laser with different power is focused, it is found that the phase change and/or transport of dissolved gas into the bubble play a dominant role in determining the bubble growth and shrinkage. Thus, we propose two stages in terms of time and three regimes depending on the incident energy, in which the evolutions of cavitation bubble in short and long time durations are distinctively identified. In regime I (lower incident power), the water nearby the focal point undergoes a phase change, resulting in an initial rapid growth of a bubble (first stage), but the convection flow due to locally heated surface causes the bubble to shrink at later times (second stage). As the laser power increases (regime III), more dissolved gas in the surrounding water enters the growing bubble and prevents the water phase from being absorbed into the bubble. Thus, the bubble growth is dominated by the dissolved gas. Between regimes I and III, there is a transitional regime II in which both the phase change of water and the dissolved gas contribute to the bubble evolution. We further our understandings by developing the relations about the time-dependency of bubble size for each stage and regime, which agree well with the measured data. The scaling relations are also validated with different conditions of liquid such as degassed water and NaCl solution. While previous studies have mostly focused on the nano- and/or microsized bubble generation in a very short time (less than 1 s), we think that the present results will extend our knowledge on how to predict and control the size of laser-induced cavitation bubble for longer time duration.</P> [FIG OMISSION]</BR>
Dynamic Changes in Helicobacter pylori Status Following Gastric Cancer Surgery
( Kichul Yoon ),( Nayoung Kim ),( Jaeyeon Kim ),( Jung Won Lee ),( Hye Seung Lee ),( Jong-chan Lee ),( Hyuk Yoon ),( Cheol Min Shin ),( Young Soo Park ),( Sang-hoon Ahn ),( Do Joong Park ),( Hyung Ho 대한소화기학회 2017 Gut and Liver Vol.11 No.2
Background/Aims: Helicobacter pylori eradication is recom-mended in patients with early gastric cancer. However, the possibility of spontaneous regression raises a question for clinicians about the need for “retesting” postoperative H. py-lori status. Methods: Patients who underwent curative gas-trectomy at Seoul National University Bundang Hospital and had a positive H. pylori status without eradication therapy at the time of gastric cancer diagnosis were prospectively enrolled in this study. H. pylori status and atrophic gastritis (AG) and intestinal metaplasia (IM) histologic status were as-sessed pre- and postoperatively. Results: One hundred forty patients (mean age, 59.0 years; 60.7% male) underwent subtotal gastrectomy with B-I (65.0%), B-II (27.1%), Roux-en-Y (4.3%), jejunal interposition (0.7%), or proximal gastrectomy (4.3%). Preoperative presence of AG (62.9%) and IM (72.9%) was confirmed. The mean period between surgery and the last endoscopic follow-up was 38.0±25.6 months. Of the 140 patients, 80 (57.1%) were found to be persistently posi-tive for H. pylori, and 60 (42.9%) showed spontaneous nega-tive conversion at least once during follow-up. Of these 60 patients, eight (13.3%) showed more complex postoperative dynamic changes between negative and positive results. The spontaneous negative conversion group showed a trend of having more postoperative IM compared to the persistent H. pylori group. Conclusions: A high percentage of spontaneous regression and complex dynamic changes in H. pylori status were observed after partial gastrectomy, especially in individ-uals with postoperative histological IM. It is better to consider postoperative eradication therapy after retesting for H. pylori. (Gut Liver 2017;11:209-215)
Choi Yonghoon,Kim Nayoung,Yoon Hyuk,Shin Cheol Min,Park Young Soo,Lee Dong Ho,Park Young Suk,Ahn Sang-Hoon,Suh Yun-Suhk,Park Do Joong,Kim Hyung Ho 거트앤리버 소화기연관학회협의회 2022 Gut and Liver Vol.16 No.3
Background/Aims: Less invasive surgical treatment is performed in East Asia to preserve postoperative digestive function and reduce complications such as postgastrectomy syndromes, but there is an issue of metachronous gastric cancer (GC) in the remaining stomach. This study aimed to analyze the incidence of metachronous GC and its risk factors in patients who had undergone partial gastrectomy. Methods: A total of 3,045 GC patients who had undergone curative gastric partial resection at Seoul National University Bundang Hospital were enrolled and analyzed retrospectively for risk factors, including age, sex, smoking, alcohol, Helicobacter pylori status, family history of GC, histological type, and surgical method. Results: Metachronous GC in the remaining stomach occurred in 35 of the 3,045 patients (1.1%): 23 in the distal gastrectomy group (18 with Billroth-I anastomosis, five with Billroth-II anastomosis), seven in the proximal gastrectomy (PG) group, and five in the pylorus-preserving gastrectomy (PPG) group. Univariate and multivariate Cox regression analyses showed that age ≥60 years (p=0.005) and surgical method used (PG or PPG, p<0.001) were related risk factors for metachronous GC, while male sex and intestinal type histology were potential risk factors. Conclusions: Metachronous GC was shown to be related to older age and the surgical method used (PG or PPG). Regular and careful follow-up with endoscopy should be performed in the case of gastric partial resection, especially in patients with male sex and intestinal type histology as well as those aged ≥60 years undergoing the PG or PPG surgical method.
Comparison between Resectable Helicobacter pylori -Negative and -Positive Gastric Cancers
( Hee Jin Kim ),( Nayoung Kim ),( Hyuk Yoon ),( Yoon Jin Choi ),( Ju Yup Lee ),( Yong Hwan Kwon ),( Kichul Yoon ),( Hyun Jin Jo ),( Cheol Min Shin ),( Young Soo Park ),( Do Joong Park ),( Hyung Ho Kim 대한소화기학회 2016 Gut and Liver Vol.10 No.2
Background/Aims: Controversy exists regarding the characteristics of Helicobacter pylori infection-negative gastric cancer (HPIN-GC). The aim of this study was to evaluate clinicopathologic features of HPIN-GC compared to H. pylori infection-positive gastric cancer (HPIP-GC) using a comprehensive analysis that included genetic and environmental factors. Methods: H. pylori infection status of 705 resectable gastric cancer patients was determined by the rapid urease test, testing for anti-H. pylori antibodies, histologic analysis and culture of gastric cancer tissue samples, and history of H. pylori eradication. HPIN-GC was defined as gastric cancer that was negative for H. pylori infection based on all five methods and that had no evidence of atrophy in histology or serology. Results: The prevalence of HPIN-GC was 4% (28/705). No significant differences with respect to age, sex, smoking, drinking, family history of gastric cancer or obesity were observed between the two groups. HPIN-GC tumors were marginally more likely to involve the cardia (14.3% for HPIN-GC vs 5.3% for HPIP-GC, p=0.068). The Lauren classification, histology, and TNM stage did not differ according to H. pylori infection status. Microsatellite instability was not different between the two groups, but p53 overexpression in HPIN-GC was marginally higher than in HPIP-GC (56.0% for HPIN-GC vs 37.0% for HPIP-GC, p=0.055). Conclusions: The prevalence of HPIN-GC was extremely low, and its clinicopathologic characteristics were similar to HPIP-GC. (Gut Liver 2016;10:212-219)
Assessing Renal Ischemia/Reperfusion Injury in Mice Using Time-Dependent BOLD and DTI at 9.4 T
Woo, Dong-Cheol,Kim, Nayoung,Lee, Do-Wan,Song, Youyol,Shim, Woo Hyun,Choi, Yoonseok,Woo, Chul-Woong,Kim, Sang-Tae,Kim, Jeong-Kon,Kim, Kyungwon,Ha, Hyun-Kwon,Lee, Jin Seong Springer-Verlag 2015 Applied magnetic resonance Vol.46 No.6
( Jiyoung Yoon ),( Seung Wook Hong ),( Kyung-do Han ),( Seung-woo Lee ),( Cheol Min Shin ),( Young Soo Park ),( Nayoung Kim ),( Dong Ho Lee ),( Joo Sung Kim ),( Hyuk Yoon ) 대한소화기기능성질환·운동학회 2024 Gut and Liver Vol.18 No.3
Background/Aims: Pneumocystis jirovecii pneumonia (PJP) is a rare but potentially fatal infection. This study was conducted to investigate the risk factors for PJP in inflammatory bowel disease (IBD) patients. Methods: This nationwide, population-based study was conducted in Korea using claims data. Cases of PJP were identified in patients diagnosed with ulcerative colitis (UC) or Crohn’s disease (CD) between 2010 and 2017, and the clinical data of each patient was analyzed. Dual and triple therapy was defined as the simultaneous prescription of two or three of the following drugs: steroids, calcineurin inhibitors, immunomodulators, and biologics. Results: During the mean follow-up period (4.6±2.3 years), 84 cases of PJP were identified in 39,462 IBD patients (31 CD and 53 UC). For CD patients, only age at diagnosis >40 years (hazard ratio [HR], 6.12; 95% confidence interval [CI], 1.58 to 23.80) was significantly associated with the risk of PJP, whereas in UC patients, diagnoses of diabetes (HR, 2.51; 95% CI, 1.19 to 5.31) and chronic obstructive pulmonary disease (HR, 3.41; 95% CI, 1.78 to 6.52) showed significant associations with PJP risk. Triple therapy increased PJP risk in both UC (HR, 3.90; 95% CI, 1.54 to 9.88) and CD patients (HR, 5.69; 95% CI, 2.32 to 14.48). However, dual therapy increased PJP risk only in UC patients (HR, 2.53; 95% CI, 1.36 to 4.70). Additionally, 23 patients (27%) received intensive care treatment, and 10 (12%) died within 30 days. Conclusions: PJP risk factors differ in CD and UC patients. Considering the potential fatality of PJP, prophylaxis should be considered for at-risk IBD patients. (Gut Liver 2024;18:489-497)